# DROSPIRENONE AND ESTRADIOL
> **ANDA218031** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2025-10-28
## Drug
- **FDA Application Number:** ANDA218031
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DROSPIRENONE AND ESTRADIOL
- **Generic name:** Drospirenone
- **Active ingredients:** DROSPIRENONE; ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **First approval:** 2025-10-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218031)
---
*AI Analytics · CC0 1.0*